Loading...
XSHG603313
Market cap542mUSD
Dec 25, Last price  
6.94CNY
1D
-3.34%
1Q
13.03%
Jan 2017
-69.45%
IPO
-51.95%
Name

Healthcare Co Ltd

Chart & Performance

D1W1MN
XSHG:603313 chart
P/E
37.15
P/S
0.50
EPS
0.19
Div Yield, %
3.83%
Shrs. gr., 5y
3.75%
Rev. gr., 5y
21.20%
Revenues
7.98b
-0.52%
673,936,095899,841,672955,806,7051,162,150,1661,377,220,1331,723,034,0512,338,803,6073,049,473,4423,831,588,3146,530,134,2538,139,254,6168,017,244,7187,975,916,437
Net income
107m
+157.74%
80,392,589113,972,617108,137,304130,824,695164,260,798200,395,514155,848,577186,073,457373,677,311378,585,689041,359,233106,600,585
CFO
917m
+62.12%
19,985,127147,328,05091,340,771114,194,886167,182,990149,698,73358,817,413175,035,816129,794,963582,525,96267,922,544565,392,835916,624,603
Dividend
Jul 14, 20210.269231 CNY/sh
Earnings
May 16, 2025

Profile

Healthcare Co., Ltd. manufactures and sells memory foam products in China. The company provides foam toppers, mattresses, sofas, and pillows. It also sells its products under the MLILY brand through company-owned retail shops. The company also exports its products to Europe, Russia, the Middle East, and North Africa. Healthcare Co., Ltd. was founded in 2003 and is based in Rugao, China.
URL
https://mlilyusa.com/
IPO date
Oct 13, 2016
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
7,975,916
-0.52%
8,017,245
-1.50%
8,139,255
24.64%
Cost of revenue
6,469,614
7,313,058
7,563,669
Unusual Expense (Income)
NOPBT
1,506,303
704,187
575,586
NOPBT Margin
18.89%
8.78%
7.07%
Operating Taxes
42,929
29,401
Tax Rate
2.85%
4.18%
NOPAT
1,463,373
674,786
575,586
Net income
106,601
157.74%
41,359
 
Dividends
(151,756)
Dividend yield
2.98%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
2,214,153
2,183,752
2,207,818
Long-term debt
3,073,682
3,188,719
2,915,031
Deferred revenue
4,229
4,572
4,915
Other long-term liabilities
192,885
158,363
112,047
Net debt
4,051,375
4,619,808
3,970,577
Cash flow
Cash from operating activities
916,625
565,393
67,923
CAPEX
(414,525)
Cash from investing activities
(399,500)
Cash from financing activities
(71,748)
363,571
FCF
1,402,479
170,170
(918,450)
Balance
Cash
1,116,455
577,535
1,055,573
Long term investments
120,005
175,127
96,699
Excess cash
837,664
351,800
745,309
Stockholders' equity
1,416,065
1,270,488
1,248,584
Invested Capital
7,117,456
6,880,074
6,368,499
ROIC
20.91%
10.19%
10.45%
ROCE
18.93%
9.67%
8.04%
EV
Common stock shares outstanding
484,548
485,299
483,429
Price
10.50
-0.94%
10.60
-38.76%
17.31
-30.59%
Market cap
5,087,755
-1.10%
5,144,170
-38.53%
8,368,160
-24.83%
EV
9,202,175
9,847,340
12,489,415
EBITDA
2,148,526
1,148,249
935,654
EV/EBITDA
4.28
8.58
13.35
Interest
337,837
182,316
140,516
Interest/NOPBT
22.43%
25.89%
24.41%